Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Editing Market Size Growth Rate by Type: 2018 VS 2023 VS 2033
1.2.2 Zinc finger nucleases (ZFNs)
1.2.3 Transcription Activator-Like Effector-based Nucleases (TALENs)
1.2.4 CRISPR-Cas system
1.3 Market by Application
1.3.1 Global Gene Editing Market Growth Rate by Application: 2018 VS 2023 VS 2033
1.3.2 Biotechnology & Pharmaceutical Companies
1.3.3 Academic & Government Research Institutes
1.3.4 Contract Research Organizations
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global Gene Editing Market Size (2018-2033)
2.2 Gene Editing Market Size across Key Geographies Worldwide: 2018 VS 2023 VS 2033
2.3 Global Gene Editing Market Size by Region (2018-2023)
2.4 Global Gene Editing Market Size Forecast by Region (2024-2033)
2.5 Global Top 10 Gene Editing Countries Ranking by Market Size
3 Gene Editing Competitive by Company
3.1 Global Gene Editing Revenue by Players
3.1.1 Global Gene Editing Revenue by Players (2018-2023)
3.1.2 Global Gene Editing Market Share by Players (2018-2023)
3.2 Global Gene Editing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Gene Editing Revenue
3.4 Global Gene Editing Market Concentration Ratio
3.4.1 Global Gene Editing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Editing Revenue in 2023
3.5 Global Key Players of Gene Editing Head office and Area Served
3.6 Global Key Players of Gene Editing, Product and Application
3.7 Global Key Players of Gene Editing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Gene Editing Breakdown Data by Type
4.1 Global Gene Editing Historic Revenue by Type (2018-2023)
4.2 Global Gene Editing Forecasted Revenue by Type (2024-2033)
5 Global Gene Editing Breakdown Data by Application
5.1 Global Gene Editing Historic Market Size by Application (2018-2023)
5.2 Global Gene Editing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Gene Editing Revenue by Company (2021-2023)
6.2 North America Gene Editing Revenue by Type (2018-2033)
6.3 North America Gene Editing Revenue by Application (2018-2033)
6.4 North America Gene Editing Revenue by Country (2018-2033)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Gene Editing Revenue by Company (2021-2023)
7.2 Europe Gene Editing Revenue by Type (2018-2033)
7.3 Europe Gene Editing Revenue by Application (2018-2033)
7.4 Europe Gene Editing Revenue by Country (2018-2033)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Gene Editing Revenue by Company (2021-2023)
8.2 Asia Pacific Gene Editing Revenue by Type (2018-2033)
8.3 Asia Pacific Gene Editing Revenue by Application (2018-2033)
8.4 Asia Pacific Gene Editing Revenue by Region (2018-2033)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Gene Editing Revenue by Company (2021-2023)
9.2 Latin America Gene Editing Revenue by Type (2018-2033)
9.3 Latin America Gene Editing Revenue by Application (2018-2033)
9.4 Latin America Gene Editing Revenue by Country (2018-2033)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Gene Editing Revenue by Company (2021-2023)
10.2 Middle East and Africa Gene Editing Revenue by Type (2018-2033)
10.3 Middle East and Africa Gene Editing Revenue by Application (2018-2033)
10.4 Middle East and Africa Gene Editing Revenue by Country (2018-2033)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Gene Editing Products and Services
11.1.4 Thermo Fisher Scientific Gene Editing Revenue in Gene Editing Business (2018-2023)
11.1.5 Thermo Fisher Scientific Gene Editing SWOT Analysis
11.1.6 Thermo Fisher Scientific Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Gene Editing Products and Services
11.2.4 Merck Gene Editing Revenue in Gene Editing Business (2018-2023)
11.2.5 Merck Gene Editing SWOT Analysis
11.2.6 Merck Recent Development
11.3 Horizo​​n Discovery
11.3.1 Horizo​​n Discovery Company Details
11.3.2 Horizo​​n Discovery Business Overview
11.3.3 Horizo​​n Discovery Gene Editing Products and Services
11.3.4 Horizo​​n Discovery Gene Editing Revenue in Gene Editing Business (2018-2023)
11.3.5 Horizo​​n Discovery Gene Editing SWOT Analysis
11.3.6 Horizo​​n Discovery Recent Development
11.4 Sangamo BioSciences
11.4.1 Sangamo BioSciences Company Details
11.4.2 Sangamo BioSciences Business Overview
11.4.3 Sangamo BioSciences Gene Editing Products and Services
11.4.4 Sangamo BioSciences Gene Editing Revenue in Gene Editing Business (2018-2023)
11.4.5 Sangamo BioSciences Gene Editing SWOT Analysis
11.4.6 Sangamo BioSciences Recent Development
11.5 Integrated DNA Technologies
11.5.1 Integrated DNA Technologies Company Details
11.5.2 Integrated DNA Technologies Business Overview
11.5.3 Integrated DNA Technologies Gene Editing Products and Services
11.5.4 Integrated DNA Technologies Gene Editing Revenue in Gene Editing Business (2018-2023)
11.5.5 Integrated DNA Technologies Gene Editing SWOT Analysis
11.5.6 Integrated DNA Technologies Recent Development
11.6 Lonza
11.6.1 Lonza Company Details
11.6.2 Lonza Business Overview
11.6.3 Lonza Gene Editing Products and Services
11.6.4 Lonza Gene Editing Revenue in Gene Editing Business (2018-2023)
11.6.5 Lonza Gene Editing SWOT Analysis
11.6.6 Lonza Recent Development
11.7 New England Biolabs
11.7.1 New England Biolabs Company Details
11.7.2 New England Biolabs Business Overview
11.7.3 New England Biolabs Gene Editing Products and Services
11.7.4 New England Biolabs Gene Editing Revenue in Gene Editing Business (2018-2023)
11.7.5 New England Biolabs Gene Editing SWOT Analysis
11.7.6 New England Biolabs Recent Development
11.8 OriGene Technologies
11.8.1 OriGene Technologies Company Details
11.8.2 OriGene Technologies Business Overview
11.8.3 OriGene Technologies Gene Editing Products and Services
11.8.4 OriGene Technologies Gene Editing Revenue in Gene Editing Business (2018-2023)
11.8.5 OriGene Technologies Gene Editing SWOT Analysis
11.8.6 OriGene Technologies Recent Development
11.9 Transposagen Biopharmaceuticals
11.9.1 Transposagen Biopharmaceuticals Company Details
11.9.2 Transposagen Biopharmaceuticals Business Overview
11.9.3 Transposagen Biopharmaceuticals Gene Editing Products and Services
11.9.4 Transposagen Biopharmaceuticals Gene Editing Revenue in Gene Editing Business (2018-2023)
11.9.5 Transposagen Biopharmaceuticals Gene Editing SWOT Analysis
11.9.6 Transposagen Biopharmaceuticals Recent Development
11.10 Editas Medicine
11.10.1 Editas Medicine Company Details
11.10.2 Editas Medicine Business Overview
11.10.3 Editas Medicine Gene Editing Products and Services
11.10.4 Editas Medicine Gene Editing Revenue in Gene Editing Business (2018-2023)
11.10.5 Editas Medicine Gene Editing SWOT Analysis
11.10.6 Editas Medicine Recent Development
11.11 CRISPR Therapeutics
11.11.1 CRISPR Therapeutics Company Details
11.11.2 CRISPR Therapeutics Business Overview
11.11.3 CRISPR Therapeutics Gene Editing Products and Services
11.11.4 CRISPR Therapeutics Gene Editing Revenue in Gene Editing Business (2018-2023)
11.11.5 CRISPR Therapeutics Recent Development
11.12 RGen Solutions
11.12.1 RGen Solutions Company Details
11.12.2 RGen Solutions Business Overview
11.12.3 RGen Solutions Gene Editing Products and Services
11.12.4 RGen Solutions Gene Editing Revenue in Gene Editing Business (2018-2023)
11.12.5 RGen Solutions Recent Development
11.13 Sigma-Aldrich
11.13.1 Sigma-Aldrich Company Details
11.13.2 Sigma-Aldrich Business Overview
11.13.3 Sigma-Aldrich Gene Editing Products and Services
11.13.4 Sigma-Aldrich Gene Editing Revenue in Gene Editing Business (2018-2023)
11.13.5 Sigma-Aldrich Recent Development
11.14 GeneCopoeia
11.14.1 GeneCopoeia Company Details
11.14.2 GeneCopoeia Business Overview
11.14.3 GeneCopoeia Gene Editing Products and Services
11.14.4 GeneCopoeia Gene Editing Revenue in Gene Editing Business (2018-2023)
11.14.5 GeneCopoeia Recent Development
11.15 Genscript Biotech
11.15.1 Genscript Biotech Company Details
11.15.2 Genscript Biotech Business Overview
11.15.3 Genscript Biotech Gene Editing Products and Services
11.15.4 Genscript Biotech Gene Editing Revenue in Gene Editing Business (2018-2023)
11.15.5 Genscript Biotech Recent Development
12 Gene Editing Market Dynamics
12.1 Gene Editing Industry Trends
12.2 Gene Editing Market Drivers
12.3 Gene Editing Market Challenges
12.4 Gene Editing Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details

List of Figure

List of Tables
Table 1. Global Gene Editing Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2023 VS 2033
Table 2. Key Players of Zinc finger nucleases (ZFNs)
Table 3. Key Players of Transcription Activator-Like Effector-based Nucleases (TALENs)
Table 4. Key Players of CRISPR-Cas system
Table 5. Global Gene Editing Market Size Growth Rate by Application (US$ Million), 2018 VS 2023 VS 2033
Table 6. Global Gene Editing Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2023 VS 2033
Table 7. Global Gene Editing Revenue by Region (2018-2023) & (US$ Million)
Table 8. Global Gene Editing Revenue Forecast by Region (2024-2033) & (US$ Million)
Table 9. Global Gene Editing Market Size of Top 10 Countries, 2018 VS 2023 VS 2033, (US$ Million)
Table 10. Global Gene Editing Revenue by Players (2018-2023) & (US$ Million)
Table 11. Global Gene Editing Market Share by Players (2018-2023)
Table 12. Global Top Gene Editing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Editing as of 2023)
Table 13. Ranking of Global Top Gene Editing Companies by Revenue (US$ Million) in 2023
Table 14. Global 5 Largest Players Market Share by Gene Editing Revenue (CR5 and HHI) & (2018-2023)
Table 15. Global Key Players of Gene Editing, Headquarters and Area Served
Table 16. Global Key Players of Gene Editing, Product and Application
Table 17. Global Key Players of Gene Editing, Date of Enter into This Industry
Table 18. Mergers & Acquisitions, Expansion Plans
Table 19. Global Gene Editing Market Size by Type (2018-2023) & (US$ Million)
Table 20. Global Gene Editing Revenue Market Share by Type (2018-2023)
Table 21. Global Gene Editing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 22. Global Gene Editing Revenue Market Share by Type (2024-2033)
Table 23. Global Gene Editing Market Size by Application (2018-2023) & (US$ Million)
Table 24. Global Gene Editing Revenue Market Share by Application (2018-2023)
Table 25. Global Gene Editing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 26. Global Gene Editing Revenue Market Share by Application (2024-2033)
Table 27. North America Gene Editing Revenue by Company (2021-2023) & (US$ Million)
Table 28. North America Gene Editing Revenue by Type (2018-2023) & (US$ Million)
Table 29. North America Gene Editing Revenue by Type (2024-2033) & (US$ Million)
Table 30. North America Gene Editing Revenue by Application (2018-2023) & (US$ Million)
Table 31. North America Gene Editing Revenue by Application (2024-2033) & (US$ Million)
Table 32. North America Gene Editing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 33. North America Gene Editing Revenue by Country (2018-2023) & (US$ Million)
Table 34. North America Gene Editing Revenue by Country (2024-2033) & (US$ Million)
Table 35. Europe Gene Editing Revenue by Company (2021-2023) & (US$ Million)
Table 36. Europe Gene Editing Revenue by Type (2018-2023) & (US$ Million)
Table 37. Europe Gene Editing Revenue by Type (2024-2033) & (US$ Million)
Table 38. Europe Gene Editing Revenue by Application (2018-2023) & (US$ Million)
Table 39. Europe Gene Editing Revenue by Application (2024-2033) & (US$ Million)
Table 40. Europe Gene Editing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 41. Europe Gene Editing Revenue by Country (2018-2023) & (US$ Million)
Table 42. Europe Gene Editing Revenue by Country (2024-2033) & (US$ Million)
Table 43. Asia Pacific Gene Editing Revenue by Company (2021-2023) & (US$ Million)
Table 44. Asia Pacific Gene Editing Revenue by Type (2018-2023) & (US$ Million)
Table 45. Asia Pacific Gene Editing Revenue by Type (2024-2033) & (US$ Million)
Table 46. Asia Pacific Gene Editing Revenue by Application (2018-2023) & (US$ Million)
Table 47. Asia Pacific Gene Editing Revenue by Application (2024-2033) & (US$ Million)
Table 48. Asia-Pacific Gene Editing Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 49. Asia Pacific Gene Editing Revenue by Region (2018-2023) & (US$ Million)
Table 50. Asia Pacific Gene Editing Revenue by Region (2024-2033) & (US$ Million)
Table 51. Latin America Gene Editing Revenue by Company (2021-2023) & (US$ Million)
Table 52. Latin America Gene Editing Revenue by Type (2018-2023) & (US$ Million)
Table 53. Latin America Gene Editing Revenue by Type (2024-2033) & (US$ Million)
Table 54. Latin America Gene Editing Revenue by Application (2018-2023) & (US$ Million)
Table 55. Latin America Gene Editing Revenue by Application (2024-2033) & (US$ Million)
Table 56. Latin America Gene Editing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 57. Latin America Gene Editing Revenue by Country (2018-2023) & (US$ Million)
Table 58. Latin America Gene Editing Revenue by Country (2024-2033) & (US$ Million)
Table 59. Middle East and Africa Gene Editing Revenue by Company (2021-2023) & (US$ Million)
Table 60. Middle East and Africa Gene Editing Revenue by Type (2018-2023) & (US$ Million)
Table 61. Middle East and Africa Gene Editing Revenue by Type (2024-2033) & (US$ Million)
Table 62. Middle East and Africa Gene Editing Revenue by Application (2018-2023) & (US$ Million)
Table 63. Middle East and Africa Gene Editing Revenue by Application (2024-2033) & (US$ Million)
Table 64. Middle East and Africa Gene Editing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 65. Middle East and Africa Gene Editing Revenue by Country (2018-2023) & (US$ Million)
Table 66. Middle East and Africa Gene Editing Revenue by Country (2024-2033) & (US$ Million)
Table 67. Thermo Fisher Scientific Company Details
Table 68. Thermo Fisher Scientific Business Overview
Table 69. Thermo Fisher Scientific Gene Editing Product and Services
Table 70. Thermo Fisher Scientific Gene Editing Revenue in Gene Editing Business (2018-2023) & (US$ Million)
Table 71. Thermo Fisher Scientific Gene Editing SWOT Analysis
Table 72. Thermo Fisher Scientific Recent Development
Table 73. Merck Company Details
Table 74. Merck Business Overview
Table 75. Merck Gene Editing Product and Services
Table 76. Merck Gene Editing Revenue in Gene Editing Business (2018-2023) & (US$ Million)
Table 77. Merck Gene Editing SWOT Analysis
Table 78. Merck Recent Development
Table 79. Horizo​​n Discovery Company Details
Table 80. Horizo​​n Discovery Business Overview
Table 81. Horizo​​n Discovery Gene Editing Product and Services
Table 82. Horizo​​n Discovery Gene Editing Revenue in Gene Editing Business (2018-2023) & (US$ Million)
Table 83. Horizo​​n Discovery Gene Editing SWOT Analysis
Table 84. Horizo​​n Discovery Recent Development
Table 85. Sangamo BioSciences Company Details
Table 86. Sangamo BioSciences Business Overview
Table 87. Sangamo BioSciences Gene Editing Product and Services
Table 88. Sangamo BioSciences Gene Editing Revenue in Gene Editing Business (2018-2023) & (US$ Million)
Table 89. Sangamo BioSciences Gene Editing SWOT Analysis
Table 90. Sangamo BioSciences Recent Development
Table 91. Integrated DNA Technologies Company Details
Table 92. Integrated DNA Technologies Business Overview
Table 93. Integrated DNA Technologies Gene Editing Product and Services
Table 94. Integrated DNA Technologies Gene Editing Revenue in Gene Editing Business (2018-2023) & (US$ Million)
Table 95. Integrated DNA Technologies Gene Editing SWOT Analysis
Table 96. Integrated DNA Technologies Recent Development
Table 97. Lonza Company Details
Table 98. Lonza Business Overview
Table 99. Lonza Gene Editing Product and Services
Table 100. Lonza Gene Editing Revenue in Gene Editing Business (2018-2023) & (US$ Million)
Table 101. Lonza Gene Editing SWOT Analysis
Table 102. Lonza Recent Development
Table 103. New England Biolabs Company Details
Table 104. New England Biolabs Business Overview
Table 105. New England Biolabs Gene Editing Product and Services
Table 106. New England Biolabs Gene Editing Revenue in Gene Editing Business (2018-2023) & (US$ Million)
Table 107. New England Biolabs Gene Editing SWOT Analysis
Table 108. New England Biolabs Recent Development
Table 109. OriGene Technologies Company Details
Table 110. OriGene Technologies Business Overview
Table 111. OriGene Technologies Gene Editing Product and Services
Table 112. OriGene Technologies Gene Editing Revenue in Gene Editing Business (2018-2023) & (US$ Million)
Table 113. OriGene Technologies Gene Editing SWOT Analysis
Table 114. OriGene Technologies Recent Development
Table 115. Transposagen Biopharmaceuticals Company Details
Table 116. Transposagen Biopharmaceuticals Business Overview
Table 117. Transposagen Biopharmaceuticals Gene Editing Product and Services
Table 118. Transposagen Biopharmaceuticals Gene Editing Revenue in Gene Editing Business (2018-2023) & (US$ Million)
Table 119. Transposagen Biopharmaceuticals Gene Editing SWOT Analysis
Table 120. Transposagen Biopharmaceuticals Recent Development
Table 121. Editas Medicine Company Details
Table 122. Editas Medicine Business Overview
Table 123. Editas Medicine Gene Editing Product and Services
Table 124. Editas Medicine Gene Editing Revenue in Gene Editing Business (2018-2023) & (US$ Million)
Table 125. Editas Medicine Gene Editing SWOT Analysis
Table 126. Editas Medicine Recent Development
Table 127. CRISPR Therapeutics Company Details
Table 128. CRISPR Therapeutics Business Overview
Table 129. CRISPR Therapeutics Gene Editing Product and Services
Table 130. CRISPR Therapeutics Gene Editing Revenue in Gene Editing Business (2018-2023) & (US$ Million)
Table 131. CRISPR Therapeutics Recent Development
Table 132. RGen Solutions Company Details
Table 133. RGen Solutions Business Overview
Table 134. RGen Solutions Gene Editing Product and Services
Table 135. RGen Solutions Gene Editing Revenue in Gene Editing Business (2018-2023) & (US$ Million)
Table 136. RGen Solutions Recent Development
Table 137. Sigma-Aldrich Company Details
Table 138. Sigma-Aldrich Business Overview
Table 139. Sigma-Aldrich Gene Editing Product and Services
Table 140. Sigma-Aldrich Gene Editing Revenue in Gene Editing Business (2018-2023) & (US$ Million)
Table 141. Sigma-Aldrich Recent Development
Table 142. GeneCopoeia Company Details
Table 143. GeneCopoeia Business Overview
Table 144. GeneCopoeia Gene Editing Product and Services
Table 145. GeneCopoeia Gene Editing Revenue in Gene Editing Business (2018-2023) & (US$ Million)
Table 146. GeneCopoeia Recent Development
Table 147. Genscript Biotech Company Details
Table 148. Genscript Biotech Business Overview
Table 149. Genscript Biotech Gene Editing Product and Services
Table 150. Genscript Biotech Gene Editing Revenue in Gene Editing Business (2018-2023) & (US$ Million)
Table 151. Genscript Biotech Recent Development
Table 152. Gene Editing Market Trends
Table 153. Gene Editing Market Drivers
Table 154. Gene Editing Market Challenges
Table 155. Gene Editing Market Restraints
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Gene Editing Product Picture
Figure 2. Global Gene Editing Market Size by Type (US$ Million): 2018 VS 2023 VS 2033
Figure 3. Global Gene Editing Market Share by Type: 2023 VS 2033
Figure 4. Zinc finger nucleases (ZFNs) Features
Figure 5. Transcription Activator-Like Effector-based Nucleases (TALENs) Features
Figure 6. CRISPR-Cas system Features
Figure 7. Global Gene Editing Market Size by Application (US$ Million): 2018 VS 2023 VS 2033
Figure 8. Global Gene Editing Market Share by Application: 2023 VS 2033
Figure 9. Biotechnology & Pharmaceutical Companies
Figure 10. Academic & Government Research Institutes
Figure 11. Contract Research Organizations
Figure 12. Gene Editing Report Years Considered
Figure 13. Global Gene Editing Revenue, (US$ Million), 2018 VS 2023 VS 2033
Figure 14. Global Gene Editing Market Size 2018-2033 (US$ Million)
Figure 15. Global Gene Editing Market Size Market Share by Region: 2023 VS 2033
Figure 16. Global Gene Editing Revenue Market Share by Region in 2018 VS 2023
Figure 17. Global Gene Editing Revenue Market Share Forecast by Region (2024-2033)
Figure 18. Global Top 10 Gene Editing Countries Ranking by Market Size (US$ Million) in 2023
Figure 19. Global Gene Editing Market Size of Top 10 Countries, 2018 VS 2023 VS 2033, (US$ Million)
Figure 20. Global Gene Editing Market Share by Players in 2023
Figure 21. Global Top Gene Editing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Editing as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by Gene Editing Revenue in 2023
Figure 23. North America Gene Editing Revenue Market Share by Company in 2023
Figure 24. North America Gene Editing Revenue Market Share by Type (2018-2033)
Figure 25. North America Gene Editing Revenue Market Share by Application (2018-2033)
Figure 26. North America Gene Editing Revenue Share by Country (2018-2033)
Figure 27. U.S. Gene Editing Revenue (2018-2033) & (US$ Million)
Figure 28. Canada Gene Editing Revenue (2018-2033) & (US$ Million)
Figure 29. Europe Gene Editing Revenue Market Share by Company in 2023
Figure 30. Europe Gene Editing Revenue Market Share by Type (2018-2033)
Figure 31. Europe Gene Editing Revenue Market Share by Application (2018-2033)
Figure 32. Europe Gene Editing Revenue Share by Country (2018-2033)
Figure 33. Germany Gene Editing Revenue (2018-2033) & (US$ Million)
Figure 34. France Gene Editing Revenue (2018-2033) & (US$ Million)
Figure 35. U.K. Gene Editing Revenue (2018-2033) & (US$ Million)
Figure 36. Italy Gene Editing Revenue (2018-2033) & (US$ Million)
Figure 37. Russia Gene Editing Revenue (2018-2033) & (US$ Million)
Figure 38. Asia Pacific Gene Editing Revenue Market Share by Company in 2023
Figure 39. Asia Pacific Gene Editing Revenue Market Share by Type (2018-2033)
Figure 40. Asia Pacific Gene Editing Revenue Market Share by Application (2018-2033)
Figure 41. Asia Pacific Gene Editing Revenue Share by Region (2018-2033)
Figure 42. China Gene Editing Revenue (2018-2033) & (US$ Million)
Figure 43. Japan Gene Editing Revenue (2018-2033) & (US$ Million)
Figure 44. South Korea Gene Editing Revenue (2018-2033) & (US$ Million)
Figure 45. India Gene Editing Revenue (2018-2033) & (US$ Million)
Figure 46. Australia Gene Editing Revenue (2018-2033) & (US$ Million)
Figure 47. Taiwan Gene Editing Revenue (2018-2033) & (US$ Million)
Figure 48. Indonesia Gene Editing Revenue (2018-2033) & (US$ Million)
Figure 49. Thailand Gene Editing Revenue (2018-2033) & (US$ Million)
Figure 50. Malaysia Gene Editing Revenue (2018-2033) & (US$ Million)
Figure 51. Philippines Gene Editing Revenue (2018-2033) & (US$ Million)
Figure 52. Vietnam Gene Editing Revenue (2018-2033) & (US$ Million)
Figure 53. Latin America Gene Editing Revenue Market Share by Company in 2023
Figure 54. Latin America Gene Editing Revenue Market Share by Type (2018-2033)
Figure 55. Latin America Gene Editing Revenue Market Share by Application (2018-2033)
Figure 56. Latin America Gene Editing Revenue Share by Country (2018-2033)
Figure 57. Mexico Gene Editing Revenue (2018-2033) & (US$ Million)
Figure 58. Brazil Gene Editing Revenue (2018-2033) & (US$ Million)
Figure 59. Argentina Gene Editing Revenue (2018-2033) & (US$ Million)
Figure 60. Middle East and Africa Gene Editing Revenue Market Share by Company in 2023
Figure 61. Middle East and Africa Gene Editing Revenue Market Share by Type (2018-2033)
Figure 62. Middle East and Africa Gene Editing Revenue Market Share by Application (2018-2033)
Figure 63. Middle East and Africa Gene Editing Revenue Share by Country (2018-2033)
Figure 64. Turkey Gene Editing Revenue (2018-2033) & (US$ Million)
Figure 65. Saudi Arabia Gene Editing Revenue (2018-2033) & (US$ Million)
Figure 66. UAE Gene Editing Revenue (2018-2033) & (US$ Million)
Figure 67. Thermo Fisher Scientific Revenue Growth Rate in Gene Editing Business (2018-2023)
Figure 68. Merck Revenue Growth Rate in Gene Editing Business (2018-2023)
Figure 69. Horizo​​n Discovery Revenue Growth Rate in Gene Editing Business (2018-2023)
Figure 70. Sangamo BioSciences Revenue Growth Rate in Gene Editing Business (2018-2023)
Figure 71. Integrated DNA Technologies Revenue Growth Rate in Gene Editing Business (2018-2023)
Figure 72. Lonza Revenue Growth Rate in Gene Editing Business (2018-2023)
Figure 73. New England Biolabs Revenue Growth Rate in Gene Editing Business (2018-2023)
Figure 74. OriGene Technologies Revenue Growth Rate in Gene Editing Business (2018-2023)
Figure 75. Transposagen Biopharmaceuticals Revenue Growth Rate in Gene Editing Business (2018-2023)
Figure 76. Editas Medicine Revenue Growth Rate in Gene Editing Business (2018-2023)
Figure 77. CRISPR Therapeutics Revenue Growth Rate in Gene Editing Business (2018-2023)
Figure 78. RGen Solutions Revenue Growth Rate in Gene Editing Business (2018-2023)
Figure 79. Sigma-Aldrich Revenue Growth Rate in Gene Editing Business (2018-2023)
Figure 80. GeneCopoeia Revenue Growth Rate in Gene Editing Business (2018-2023)
Figure 81. Genscript Biotech Revenue Growth Rate in Gene Editing Business (2018-2023)
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed